Skip to Main Content

Editorial Board

Editor-in-Chief

Aung Naing, MD, FACP
Associate Professor, Investigational Cancer Therapeutics, The University of Texas MD Anderson Cancer Center, Houston, TX, USA

Associate Editors

Jordi Rodon Ahnert, MD
Associate Professor, Investigational Cancer Therapeutics, The University of Texas MD Anderson Cancer Center, Houston, TX, USA

Timothy A Yap, MD
Associate Professor, Investigational Cancer Therapeutics, The University of Texas MD Anderson Cancer Center, Houston, TX, USA

Editorial Board Members

Michael B. Atkins, MD
Deputy Director, Georgetown-Lombardi Comprehensive Cancer Center; Professor and Vice-Chair, Department of Oncology, Georgetown University Medical Center, Washington, DC, USA

Mark Basik, MD
Associate Professor, Department of Surgery and Oncology, Jewish General Hospital, Montreal, QC, Canada

Mehmet Asim Bilen, MD
Emory University, Atlanta, GA, USA

Helen Chen, MD
Senior Investigator and Medical Officer, Associate Chief, Investigational Drug Branch, Cancer Therapy Evaluation Program (CTEP), National Cancer Institute, Bethesda, MD, USA

Gerald Falchook, MD, MS
Director, Drug Development Unit, Sarah Cannon Research Institute at HealthONE, Denver, CO, USA

Ignacio Garrido-Laguna, MD
Associate Professor, Gastrointestinal Oncology; Associate Director of Phase 1 Program, Division of Oncology, Department of Internal Medicine, Huntsman Cancer Institute, University of Utah School of Medicine, Salt Lake City, UT, USA

Joud Hajjar, MD
Assistant Professor, Service Chief of Adult Allergy and Immunology, Section of Immunology, Allergy, and Rheumatology, Baylor College of Medicine and Texas Children Hospital, Houston, TX, USA

Dov Hershkovitz, MD
Tel-Aviv University, Tel-Aviv Sourasky Medical Center, Tel-Aviv, Israel

Sungjune Kim, MD, PhD
Departments of Radiation Oncology and Immunology, H. Lee. Moffitt Cancer Center & Research Institute; Assistant Professor, Department of Oncologic Sciences, University of South Florida, Tampa, FL, USA

Matthew Krebs, MD
Senior Clinical Lecturer, Division of Cancer Sciences, Department of Biology, Medicine, and Health, The University of Manchester; Consultant in Medical Oncology, Experimental Cancer Medicine Team, The Christie NHS Foundation Trust, Manchester, UK

Valerae O. Lewis, MD
Professor and Chair, Department of Orthopedic Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA

Chia-Chi Lin, MD
Director of Phase 1 Center, Department of Oncology, National Taiwan University Hospital, Taiwan

Herbert Loong, MD
Clinical Assistant Professor, Department of Clinical Oncology; Deputy Medical Director, Phase 1 Clinical Trials Centre, The Chinese University of Hong Kong, Prince of Wales Hospital, Hong Kong, China

Juanita Lopez, MD
Consultant in Medical Oncology, Drug Development Phase 1 Unit, Royal Marsden Hospital and The Institute of Cancer Research, London, UK

Christophe Massard, MD
Senior Consultant, Department of Drug Development, Department of Medical Oncology, Gustave Roussy, Villejuif, France

Jennifer McQuade, MD
The University of Texas MD Anderson Cancer Center, Houston, TX, USA

Rowan Miller, MD
Consultant Medical Oncologist, University College London Hospital, London, UK

Gil Morgan, MD
Department of Oncology, Skåne University Hospital, Lund, Sweden

Paolo Nuciforo, MD
Principal Investigator, Molecular Oncology Group, Vall d’Hebron Institute of Oncology (VHIO), Vall d’Hebron University Hospital, Barcelona, Spain

Naveen Pemmaraju, MD
Associate Professor, Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX, USA

Sophie Postel-Vinay, MD
Assistant Professor, Department of Drug Development, Institut de Cancérologie, Gustave Roussy, Villejuif, France

Christian Rolfo, MD
Professor, Director of Thoracic Medical Oncology, Director of Early Clinical Trials, Marlene and Stewart Greenebaum Comprehensive Cancer Center, University of Maryland School of Medicine, Baltimore, MD, USA

Patricia Roxburgh, MD
Senior Clinical Lecturer, Experimental Therapeutics, Institute of Cancer Sciences, University of Glasgow, Glasgow, Scotland

Nina Niu Sanford, MD
Assistant Professor, Department of Radiation Oncology, University of Texas Southwestern, Dallas, TX, USA

Ajay Sheshadri, MD
Assistant Professor, Pulmonary Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX, USA

Close Modal
This Feature Is Available To Subscribers Only

Sign In or Create an Account

Close Modal
Close Modal